ORGANO CORPORATION

Transcripts Organo Corporation

Equities

6368

JP3201600008

Market Closed - Japan Exchange Other stock markets 07:00:00 09/05/2024 BST			5-day change	1st Jan Change
8,020 ^JPY	+0.25%		+7.80%	+37.33%

02-09	Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	CI
2023	Organo Corporation Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2023 and Fiscal Year Ending March 31, 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	07/11/22	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and Fiscal Year Ending March 31, 2023	05/08/22	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and Fiscal Year Ending March 31, 2023	12/05/22	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	07/02/22	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	05/11/21	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2021 and Fiscal Year Ending March 31, 2022	05/08/21	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2021 and Fiscal Year Ending March 31, 2022	11/05/21	CI
Organo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2021	04/02/21	CI
Organo Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2021	28/10/20	CI
Organo Corporation Provides Earnings Guidance for the First Half Ending September 30, 2020 and Full Year Ending March 31, 2021	03/08/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer